Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis

Background Obesity and hypercholesterolemia independently increase cardiovascular disease risk. This analysis evaluated the efficacy and safety of bempedoic acid in people with obesity participating in the CLEAR (Cholesterol Lowering via Bempedoic Acid [ECT1002], an ACL‐Inhibiting Regimen) Outcomes...

Full description

Bibliographic Details

Published in:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Main Authors:	Harold E. Bays, LeAnne Bloedon, Danielle Brennan, Lei Lei, A. Michael Lincoff, Stephen J. Nicholls, Jorge Plutzky, Heather A. Powell, Steven E. Nissen
Format:	Article
Language:	English
Published:	Wiley 2025-02-01
Subjects:	bempedoic acid cardiovascular disease cardiovascular risk lipid lowering obesity statin intolerance
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.124.037898